Fate Therapeutics (FATE) announced that the U.S. Food and Drug Administration, FDA, granted Regenerative Medicine Advanced Therapy, RMAT, designation to FT819, an investigational, off-the-shelf ...

nNOS U.S., a subsidiary of Beyond Air (XAIR), was granted FDA orphan designation for its treatment of Phelan-McDermid syndrome, according to a post to the agency’s website. Discover ...

This car is no longer available for purchase. You can still find your dream car! Browse our live and coming soon auctions or search our classifieds.